Beijing's Novogene Closes $75 Million B Round for Genomic Sequencing

Novogene Technology of Beijing closed a $75 million Series B round that was funded by China investors. Novogene, which has one of the largest sequencing capacities in the world, offers next-generation sequencing and bioinformatics services to biopharmas and hospitals. One year ago, Novogene formed a partnership with Illumina to develop clinical oncology diagnostics. Founded in 2011 by Dr. Ruiquiang Li, Novogene has nearly 1,000 employees in locations around the world. More details.... Stock Symbol: (NSDQ: ILMN) Share this with colleagues: // //